#8601. Correction to Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study (The Lancet Global Health (20XX) 9(11) (e1600–e1609), (S2214109X21003041), (10.1016/S2214-109X(21)00304-1))

January 2027publication date
Proposal available till 30-05-2025
4 total number of authors per manuscript4500 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Medicine (all);
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeFreeFree
1350 $1200 $1050 $900 $
Contract №8601.1 Contract №8601.2 Contract №8601.3 Contract №8601.4
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)

Abstract:
In this study, we examine whether it is feasible and acceptable to add HBV testing and treatment of pregnant women to prevent the perinatal transmission of hepatitis B virus. The role of infant birth-dose vaccination was also investigated.
Keywords:
hepatitis B virus; pregnancy; birth-dose vaccine; mother-to-child transmission

Contacts :
0